Literature DB >> 19103860

Newborn screening for sickle cell disease in the Republic of Benin.

M C Rahimy1, A Gangbo, G Ahouignan, E Alihonou.   

Abstract

AIMS: To develop a strategy for neonatal screening of sickle cell disease (SCD) and effective enrollment of affected neonates in a comprehensive follow-up programme adapted to the socioeconomic conditions, health structures and cultural background of an African setting.
METHODS: The strategy implemented at the two largest maternity services of Cotonou, the economic capital of the Republic of Benin, involves a team of specifically trained midwives, first to identify pregnant women at risk, and second to provide active and repeated information and sensitisation to these women to encourage voluntary demand for newborn screening and enrollment in the follow-up programme.
RESULTS: Among the consecutive pregnant women studied (about 3000), 79.5% of the informed women at risk for fetal SCD asked for testing of their offspring, 85.2% of the newborns who tested positive were enrolled in the programme, and more than 80% were still being followed up after 5 years. The under-five mortality rate in this series was 15.5 per 10,000, a figure that is 10 times lower than the general rate recorded in the Republic of Benin.
CONCLUSIONS: The results demonstrate that this specifically tailored strategy is relevant to this setting, given the unique conditions of this African country.

Entities:  

Mesh:

Year:  2009        PMID: 19103860     DOI: 10.1136/jcp.2008.059113

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  41 in total

1.  High mortality from Plasmodium falciparum malaria in children living with sickle cell anemia on the coast of Kenya.

Authors:  Charlotte F McAuley; Clare Webb; Julie Makani; Alexander Macharia; Sophie Uyoga; Daniel H Opi; Carolyne Ndila; Antony Ngatia; John Anthony G Scott; Kevin Marsh; Thomas N Williams
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

2.  Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.

Authors:  Venée N Tubman; Roseda Marshall; Wilhemina Jallah; Dongjing Guo; Clement Ma; Kwaku Ohene-Frempong; Wendy B London; Matthew M Heeney
Journal:  Pediatr Blood Cancer       Date:  2016-01-06       Impact factor: 3.167

3.  Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.

Authors:  Patrick T McGann; Thomas N Williams; Peter Olupot-Olupot; George A Tomlinson; Adam Lane; José Luís Reis da Fonseca; Robert Kitenge; George Mochamah; Ham Wabwire; Susan Stuber; Thad A Howard; Kathryn McElhinney; Banu Aygun; Teresa Latham; Brígida Santos; Léon Tshilolo; Russell E Ware
Journal:  Am J Hematol       Date:  2018-01-27       Impact factor: 10.047

4.  A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.

Authors:  Patrick T McGann; Scott D Grosse; Brigida Santos; Vysolela de Oliveira; Luis Bernardino; Nicholas J Kassebaum; Russell E Ware; Gladstone E Airewele
Journal:  J Pediatr       Date:  2015-10-23       Impact factor: 4.406

5.  Community engagement to inform the development of a sickle cell counselor training and certification program in Ghana.

Authors:  Kofi A Anie; Marsha J Treadwell; Althea M Grant; Jemima A Dennis-Antwi; Mabel K Asafo; Mary E Lamptey; Jelili Ojodu; Careema Yusuf; Ayo Otaigbe; Kwaku Ohene-Frempong
Journal:  J Community Genet       Date:  2016-04-18

Review 6.  Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.

Authors:  Junaid Ansari; Youmna E Moufarrej; Rafal Pawlinski; Felicity N E Gavins
Journal:  Expert Rev Hematol       Date:  2017-12-05       Impact factor: 2.929

Review 7.  The pressing need for point-of-care diagnostics for sickle cell disease: A review of current and future technologies.

Authors:  Patrick T McGann; Carolyn Hoppe
Journal:  Blood Cells Mol Dis       Date:  2017-08-08       Impact factor: 3.039

8.  Hemoglobin variants identified in the Uganda Sickle Surveillance Study.

Authors:  Beverly A Schaefer; Charles Kiyaga; Thad A Howard; Grace Ndeezi; Arielle G Hernandez; Isaac Ssewanyana; Mary C Paniagua; Christopher M Ndugwa; Jane R Aceng; Russell E Ware
Journal:  Blood Adv       Date:  2016-11-22

9.  Acceptability of prenatal diagnosis by a sample of parents of sickle cell anemia patients in Cameroon (sub-Saharan Africa).

Authors:  Ambroise Wonkam; Alfred K Njamnshi; Dora Mbanya; Jeanne Ngogang; Caryl Zameyo; Fru F Angwafo
Journal:  J Genet Couns       Date:  2011-05-21       Impact factor: 2.537

10.  Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening.

Authors:  Amanda R Burnham-Marusich; Chinenye O Ezeanolue; Michael C Obiefune; Wei Yang; Alice Osuji; Amaka G Ogidi; Aaron T Hunt; Dina Patel; Echezona E Ezeanolue
Journal:  Public Health Genomics       Date:  2016-09-10       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.